To conduct the STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma, Starton Therapeutics contracts with a global clinical research organization
In: Plus Company Updates, 2023-07-11
Zeitungsartikel
Zugriff:
Titel: |
To conduct the STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma, Starton Therapeutics contracts with a global clinical research organization
|
---|---|
Zeitschrift: | Plus Company Updates, 2023-07-11 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|